PubMed Coskun, T., Urva, S., Roell, W.C., Qu, H., Loghin, C., Moyers, J.S., OFarrell, L.S., Briere, D.A., Sloop, K.W., Thomas, M.K., Pirro, V., Wainscott, D.B., Willard, F.S., Abernathy, M., Morford, L., Du, Y., Benson, C., Gimeno, R.E., Haupt, A., & Milicevic, Z
There is not yet a lot of evidence regarding the efficacy of microdosing GLP-1s, and no microdose of a GLP-1 has FDA approval, so check with your doctor for the latest recommendations before starting a microdosing program
Blood Sugar Control : Semaglutide is also beneficial for people with type 2 diabetes or those at risk of developing diabetes
Examples include dulaglutide, exenatide extended-release, liraglutide and semaglutide (injectable and oral)
Caffeine doesn't block or diminish tirzepatide's appetite-suppressing or glucose-lowering effects